Rapid Microbial Identification System that revolutionizes the pathogenic bacteria diagnostic process. This system can detect and identify, within minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. The process has been verified by North American Science Associates, Inc. (NAMSA), and has been through an extensive evaluation by the AOAC RI Institute.
Expected to sign a deal with MMTC According to new research from the MIT Program on the Pharmaceutical Industry (POPI), many companies today are searching for ways to increase productivity, decrease costs, and develop new treatment modalities that will enhance profitability. POPI has elected to sign a distribution agreement throughout the year 2015 and has signed an agreement up to $6,000,000 guranteed for the year ending 2012.
Another partner in agreements.....
The Production in the Innovation Economy project brings together MIT faculty from a variety of disciplines -- economics, engineering, political science, management, biology, and others -- to look at U.S. industry in comparative perspective. The PIE Commission is chaired by Professor Suzanne Berger (Political Science) and Professor Phillip Sharp look to announce an agreement with MMTC as late as the date ending 8/19/2011 More details will be announced later in the week.